Opportunity Information: Apply for RFA 114 11 000001
Apply for RFA 114 11 000001
- The Georgia USAID Tbilisi in the health sector is offering a public funding opportunity titled "Georgia Tuberculosis Prevention Project" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Jan 26, 2011 and posted on Dec 23, 2010.
- Applicants must submit their applications by Feb 18, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,450,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $4,450,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Georgia Tuberculosis Prevention Project is a USAID-funded health opportunity aimed at sustaining and strengthening tuberculosis (TB) control efforts in Georgia after the conclusion of USAID/Georgia's prior activity, the Tuberculosis Treatment and Control Program, which was scheduled to end in March 2011. USAID notes it has supported TB control in Georgia since 2003 and describes itself as the largest bilateral donor working on TB in the country. This new project is positioned as a continuation of that long-term engagement, with a sharper emphasis on interventions where USAID funding is expected to have the greatest impact not only on controlling TB, but also on reducing the overall number of TB cases nationwide.
The project focuses on three main programmatic priorities that reflect a shift toward earlier detection, stronger nationwide service quality, and facility-level improvements. First, it proposes training and awareness-building for general medical practitioners so they can better recognize TB symptoms and refer or diagnose cases sooner. The underlying goal is to reduce transmission by identifying infectious cases earlier, before patients remain undiagnosed in the community for extended periods. Second, it supports technical training and monitoring for DOTS clinics across the country. DOTS (Directly Observed Treatment, Short-course) is the standard TB control approach that emphasizes standardized treatment with supervision and patient support; by expanding training and monitoring nationally rather than concentrating on a few regions, the activity is meant to raise consistency and quality of TB services across Georgia. Third, it includes the rehabilitation of selected TB outpatient clinics nationwide, indicating that some grant resources may be directed toward upgrading or improving outpatient clinical infrastructure to better support TB diagnosis, treatment, and patient management.
From a funding and administrative standpoint, this opportunity was issued as a discretionary Cooperative Agreement, meaning USAID anticipated substantial involvement during implementation compared with a more hands-off grant. The opportunity was expected to result in one award, with an estimated total funding level of $4,450,000. The award ceiling was $4,450,000 and the award floor was $2,000,000, suggesting applicants could propose different scopes and budgets within that range. There was no cost sharing or matching requirement, which typically lowers barriers for applicants that may not have significant non-federal funds available.
Eligibility was listed as unrestricted, open to any type of entity, subject to any additional clarifications that may have been included in the full announcement. The CFDA number associated with the opportunity was 98.001, USAID Foreign Assistance for Programs Overseas. The funding opportunity number was RFA 114 11 000001 and the title was Georgia Tuberculosis Prevention Project. The posting timeline indicates the opportunity was posted on December 23, 2010, with an original closing date of February 5, 2011, later extended to a current closing date of February 18, 2011, and archived on March 7, 2011. The issuing office is identified as USAID Georgia in Tbilisi.
For applicants or interested parties who had trouble accessing the full announcement electronically, the contact listed was Yana Adelberg, Acquisition Specialist, with a phone number of 995 32 544144.
FAQs: Georgia Tuberculosis Prevention Project (USAID)
What is the Georgia Tuberculosis Prevention Project?
The Georgia Tuberculosis Prevention Project is a USAID-funded health activity focused on sustaining and strengthening tuberculosis (TB) control efforts in Georgia. It was positioned as a follow-on effort after the conclusion of USAID/Georgia's prior Tuberculosis Treatment and Control Program (scheduled to end in March 2011).
Why was this project created?
USAID described the project as a continuation of its long-term support to TB control in Georgia (noting support since 2003). The project emphasized directing funding toward interventions expected to have the greatest impact on TB control and on reducing the overall number of TB cases nationwide.
What are the main program priorities of the project?
The opportunity described three main priorities:
- Earlier detection through provider training and awareness: Training and awareness-building for general medical practitioners to better recognize TB symptoms and refer or diagnose cases sooner.
- Nationwide DOTS clinic training and monitoring: Technical training and monitoring to improve consistency and quality of TB services across DOTS clinics nationwide.
- Rehabilitation of selected TB outpatient clinics: Upgrades or improvements to selected outpatient TB clinics to better support diagnosis, treatment, and patient management.
What is the goal of training general medical practitioners?
The goal is to reduce TB transmission by identifying infectious cases earlier, before patients remain undiagnosed in the community for extended periods. The opportunity highlighted earlier recognition of symptoms and quicker referral/diagnosis as key outcomes of this approach.
What is DOTS, as referenced in the opportunity?
DOTS stands for Directly Observed Treatment, Short-course. It is described in the opportunity as the standard TB control approach emphasizing standardized treatment with supervision and patient support.
Why does the project focus on DOTS clinics nationwide rather than a few regions?
The opportunity stated that expanding training and monitoring nationally (rather than concentrating on a small number of regions) was intended to raise the consistency and overall quality of TB services across Georgia.
Does the opportunity include facility or infrastructure improvements?
Yes. The opportunity included the rehabilitation of selected TB outpatient clinics nationwide, indicating that some resources could support upgrades or improvements to outpatient clinic infrastructure.
What type of funding mechanism was used for this opportunity?
This opportunity was issued as a discretionary Cooperative Agreement. The announcement indicated USAID anticipated substantial involvement during implementation compared with a more hands-off grant.
How many awards was USAID expecting to make?
The opportunity was expected to result in one award.
What was the estimated total funding available?
The estimated total funding level was $4,450,000.
What were the award ceiling and floor?
The award ceiling was $4,450,000 and the award floor was $2,000,000. This suggested applicants could propose different scopes and budgets within that range.
Was cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement.
Who was eligible to apply?
Eligibility was listed as unrestricted, open to any type of entity, subject to any additional clarifications that may have been included in the full announcement.
What is the CFDA number for this opportunity?
The CFDA number associated with the opportunity was 98.001, USAID Foreign Assistance for Programs Overseas.
What is the funding opportunity number and title?
The funding opportunity number was RFA 114 11 000001 and the title was Georgia Tuberculosis Prevention Project.
When was the opportunity posted and when did it close?
The opportunity was posted on December 23, 2010. The original closing date was February 5, 2011, later extended to a current closing date of February 18, 2011. It was archived on March 7, 2011.
Which USAID office issued this opportunity?
The issuing office was identified as USAID Georgia in Tbilisi.
Who was the listed contact for access issues with the announcement?
For applicants or interested parties who had trouble accessing the full announcement electronically, the contact listed was Yana Adelberg, Acquisition Specialist, phone: 995 32 544144.
How does this project relate to USAID's prior TB work in Georgia?
USAID stated it had supported TB control in Georgia since 2003 and described itself as the largest bilateral donor working on TB in the country. This project was described as a continuation of that engagement after the prior Tuberculosis Treatment and Control Program was scheduled to end in March 2011.
Browse more opportunities from the same agency: Georgia USAID Tbilisi
Browse more opportunities from the same category: Health
Next opportunity: Dynamic Air Quality Management
Previous opportunity: NIAID Science Education Awards (R25)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 114 11 000001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 114 11 000001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Studies at the Animal Human Interface of Influenza and Other Zoonotic Diseases in Vietnam Apply for RFA IP 11 005 Funding Number: RFA IP 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Influenza and Other Respiratory Diseases in Southern Hemisphere Apply for RFA IP 11 014 Funding Number: RFA IP 11 014 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Campus Suicide Prevention Grants Apply for SM 11 002 Funding Number: SM 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $102,000 |
| Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention Apply for SM 11 001 Funding Number: SM 11 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $480,000 |
| Cooperative Agreement with the Catholic Relief Services (CRS) Apply for CDC RFA GH11 11104 Funding Number: CDC RFA GH11 11104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India Apply for RFA IP 11 012 Funding Number: RFA IP 11 012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Influenza Vaccine Efficacy in Tropical and Developing Countries Apply for RFA IP 11 013 Funding Number: RFA IP 11 013 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantee Sites Apply for HRSA 11 101 Funding Number: HRSA 11 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Sustainable Responses for Improving the Lives of Vulnerable Children and their Households Apply for RFA 617 11 000001 Funding Number: RFA 617 11 000001 Agency: Uganda USAID Kampala Category: Health Funding Amount: $29,500,000 |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Apply for PA 11 087 Funding Number: PA 11 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Apply for PA 11 088 Funding Number: PA 11 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Apply for PA 11 089 Funding Number: PA 11 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NHLBI Investigator Initiated Resource Related Research Projects (R24) Apply for PAR 11 090 Funding Number: PAR 11 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Access to Emergency Devices Apply for HRSA 11 088 Funding Number: HRSA 11 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Emerging Infections Sentinel Network (EISN) Research Apply for RFA CK 11 002 Funding Number: RFA CK 11 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $407,000 |
| Effectiveness in an Intervention to Promote a Targeted Vaccination Program in the Obstetrician Gynecologist Setting Apply for RFA IP 11 009 Funding Number: RFA IP 11 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| National Center for Chronic Disease Prevention and Health Promotion Conference Support Program Apply for CDC RFA DP11 1102 Funding Number: CDC RFA DP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Genomic Resource Grants for Community Resource Projects (U41) Apply for PAR 11 095 Funding Number: PAR 11 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhanced Surveillance for New Vaccine Preventable Disease Apply for RFA IP 11 010 Funding Number: RFA IP 11 010 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Affordable Care Act Health Center Planning Grants Apply for HRSA 11 021 Funding Number: HRSA 11 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 114 11 000001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.